Home > Share Market > Stocks > Strides pharma science > Financial Statements> STAR Profit & Loss

Strides Pharma Science Ltd Financial Statements

Profit & Loss Statement of Strides Pharma Science Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 3,316 2,752 2,839 2,755
yoy growth (%) 20.50 (3.10) 3.05 (3.70)
Raw materials (1,333) (1,122) (1,379) (1,281)
As % of sales 40.20 40.80 48.60 46.50
Employee costs (550) (443) (434) (419)
As % of sales 16.60 16.10 15.30 15.20
Other costs (798) (671) (630) (528)
As % of sales 24.10 24.40 22.20 19.20
Operating profit 635 516 397 527
OPM 19.10 18.70 14 19.10
Depreciation (206) (174) (154) (126)
Interest expense (150) (156) (196) (183)
Other income 51.40 53.10 94.10 161
Profit before tax 330 240 140 379
Taxes (32) (11) (9.70) (63)
Tax rate (9.60) (4.70) (6.90) (17)
Minorities and other 24.70 (7) 590 120
Adj. profit 323 221 721 436
Exceptional items 43.40 (78) (44) (36)
Net profit 268 36.40 660 400
yoy growth (%) 638 (94) 65.20 268
NPM 8.10 1.32 23.30 14.50

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000